Skip to main content

Cookies on the NHS England website

We’ve put some small files called cookies on your device to make our site work.

We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.

Let us know if this is OK. We’ll use a cookie to save your choice. You canĀ read more about our cookies before you choose.

 

Creating a new NHS England: NHS Digital and NHS England have now merged. Health Education England will join us in April 2023. Learn more.

  • Home
  • News
  • Publications
  • Statistics
  • Blogs
  • Events
  • Contact us
NHS England
  • About us
  • Our work
  • Commissioning
  • Get involved
  • Coronavirus

Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

Document first published:
29 October 2020
Page updated:
18 February 2021
Topic:
Commissioning, Specialised commissioning
Publication type:
Policy or strategy

Document

Clinical Commissioning Policy Statement: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

Clinical Commissioning Policy Statement: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

  • PDF
  • 48 KB
  • 3 pages

Document

Clinical priorities advisory group: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

Clinical priorities advisory group: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

  • PDF
  • 45 KB
  • 3 pages

Document

Evidence review: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

Evidence review: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

  • PDF
  • 58 KB
  • 5 pages

Document

Compliance with equality / inequalities legislation in the formation of clinical commissioning policy propositions: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

Compliance with equality / inequalities legislation in the formation of clinical commissioning policy propositions: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

  • PDF
  • 41 KB
  • 2 pages

Document

Engagement report: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

Engagement report: Bendamustine for relapsed/refractory classical Hodgkin lymphoma (all ages)

  • PDF
  • 77 KB
  • 3 pages
  • Terms and conditions
  • Privacy and cookies
  • Social media and comment moderation
  • How could this website work better for you?
  • Accessibility statement
  • Open Government Licence v3.0
  • Sign up to our email bulletins
  • Follow us on Twitter
  • Follow us on Facebook
  • Find us on Instagram
  • Visit us on LinkedIn
  • Watch videos on YouTube
  • All RSS
NHS website